Acquired Bleeding Disorder Completed Phase 1 Trials for Catridecacog (DB09310)

IndicationStatusPhase
DBCOND0030736 (Acquired Bleeding Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01153997Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersTreatment
NCT02239146Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary BypassTreatment